CHERYL BAZZLE: Open Payments
NPI 1942419643 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 31 payments from 11 companies in 2025. Trend: 2023 $869 · 2024 $461 · 2025 $798
Food & beverage: $689Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $199 |
| Amgen Inc. | 4 | $134 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Lundbeck LLC | 4 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Exact Sciences Corporation | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: REXULTI, CAPLYTA, AUSTEDO XR, REPATHA, OTEZLA, INGREZZA, Kerendia, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
